Absci (ABSI) Net Cash Flow Growth (5y) (2025 - 2026)

Absci (ABSI) Net Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,042.03 Bn	67,041.74 Bn	-
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	471.84 Bn	467.05 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.13 Bn	114.88 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.01 Bn	61.26 Bn	3.31 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-
8	Argenx Se	55.93 Bn	50.74 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.49 Bn	34.48 Bn	959.66 Mn
10	Absci	1.18 Bn	1.06 Bn	-

Download Data